Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Short-term Investments (2016 - 2025)

National Healthcare (NHC) has disclosed Short-term Investments for 16 consecutive years, with $163.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 16.36% year-over-year to $163.0 million, compared with a TTM value of $163.0 million through Dec 2025, up 16.36%, and an annual FY2025 reading of $163.0 million, up 16.36% over the prior year.
  • Short-term Investments was $163.0 million for Q4 2025 at National Healthcare, down from $166.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $166.8 million in Q3 2025 and bottomed at $484000.0 in Q1 2024.
  • Average Short-term Investments over 5 years is $101.1 million, with a median of $109.4 million recorded in 2022.
  • The sharpest move saw Short-term Investments plummeted 99.53% in 2024, then surged 31467.15% in 2025.
  • Year by year, Short-term Investments stood at $113.1 million in 2021, then plummeted by 79.55% to $23.1 million in 2022, then skyrocketed by 380.28% to $111.1 million in 2023, then increased by 26.05% to $140.1 million in 2024, then grew by 16.36% to $163.0 million in 2025.
  • Business Quant data shows Short-term Investments for NHC at $163.0 million in Q4 2025, $166.8 million in Q3 2025, and $146.6 million in Q2 2025.